Annual Current Liabilities
$97.76 M
+$20.57 M+26.66%
December 31, 2024
Summary
- As of March 1, 2025, AUPH annual total current liabilities is $97.76 million, with the most recent change of +$20.57 million (+26.66%) on December 31, 2024.
- During the last 3 years, AUPH annual current liabilities has risen by +$57.12 million (+140.52%).
- AUPH annual current liabilities is now at all-time high.
Performance
AUPH Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$97.76 M
+$19.15 M+24.37%
December 31, 2024
Summary
- As of March 1, 2025, AUPH quarterly total current liabilities is $97.76 million, with the most recent change of +$19.15 million (+24.37%) on December 31, 2024.
- Over the past year, AUPH quarterly current liabilities has increased by +$20.86 million (+27.13%).
- AUPH quarterly current liabilities is now at all-time high.
Performance
AUPH Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AUPH Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.7% | +27.1% |
| 3 y3 years | +140.5% | +134.1% |
| 5 y5 years | +765.5% | +134.1% |
AUPH Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.5% | at high | +188.9% |
| 5 y | 5-year | at high | +765.5% | at high | +765.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Aurinia Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $97.76 M(+26.7%) | $97.76 M(+24.4%) |
| Sep 2024 | - | $78.61 M(+2.2%) |
| Jun 2024 | - | $76.90 M(+8.2%) |
| Mar 2024 | - | $71.05 M(-7.9%) |
| Dec 2023 | $77.19 M(+67.4%) | $77.19 M(+4.5%) |
| Sep 2023 | - | $73.89 M(+19.8%) |
| Jun 2023 | - | $61.66 M(+46.7%) |
| Mar 2023 | - | $42.05 M(-8.8%) |
| Dec 2022 | $46.11 M(+13.4%) | $46.11 M(+10.4%) |
| Sep 2022 | - | $41.77 M(+20.6%) |
| Jun 2022 | - | $34.63 M(+2.3%) |
| Mar 2022 | - | $33.84 M(-16.7%) |
| Dec 2021 | $40.65 M(+27.0%) | $40.65 M(+8.3%) |
| Sep 2021 | - | $37.54 M(+28.0%) |
| Jun 2021 | - | $29.32 M(+38.6%) |
| Mar 2021 | - | $21.15 M(-33.9%) |
| Dec 2020 | $32.00 M(+183.3%) | $32.00 M(+33.9%) |
| Sep 2020 | - | $23.89 M(+39.4%) |
| Jun 2020 | - | $17.14 M(+20.9%) |
| Mar 2020 | - | $14.18 M(+25.5%) |
| Dec 2019 | $11.29 M(+55.6%) | $11.29 M(-16.4%) |
| Sep 2019 | - | $13.52 M(+85.1%) |
| Jun 2019 | - | $7.30 M(+12.4%) |
| Mar 2019 | - | $6.50 M(-10.5%) |
| Dec 2018 | $7.26 M(-10.9%) | $7.26 M(+5.5%) |
| Sep 2018 | - | $6.88 M(+35.6%) |
| Jun 2018 | - | $5.08 M(-4.4%) |
| Mar 2018 | - | $5.31 M(-34.8%) |
| Dec 2017 | $8.15 M(+2.8%) | $8.15 M(+18.9%) |
| Sep 2017 | - | $6.86 M(+89.0%) |
| Jun 2017 | - | $3.63 M(-56.4%) |
| Mar 2017 | - | $8.32 M(+4.9%) |
| Dec 2016 | $7.93 M(+119.2%) | $7.93 M(+66.4%) |
| Sep 2016 | - | $4.77 M(+21.6%) |
| Jun 2016 | - | $3.92 M(+7.7%) |
| Mar 2016 | - | $3.64 M(+0.7%) |
| Dec 2015 | $3.62 M(+27.5%) | $3.62 M(-8.8%) |
| Sep 2015 | - | $3.96 M(+6.5%) |
| Jun 2015 | - | $3.72 M(+55.3%) |
| Mar 2015 | - | $2.40 M(-15.5%) |
| Dec 2014 | $2.84 M(-53.1%) | $2.84 M(+6.8%) |
| Sep 2014 | - | $2.65 M(-43.9%) |
| Jun 2014 | - | $4.73 M(+5.5%) |
| Mar 2014 | - | $4.49 M(-25.8%) |
| Dec 2013 | $6.05 M(+64.9%) | $6.05 M(-12.9%) |
| Sep 2013 | - | $6.95 M(+55.4%) |
| Jun 2013 | - | $4.47 M(+9.0%) |
| Mar 2013 | - | $4.10 M(+11.8%) |
| Dec 2012 | $3.67 M(+72.6%) | $3.67 M(+10.4%) |
| Sep 2012 | - | $3.32 M(+10.5%) |
| Jun 2012 | - | $3.01 M(+145.8%) |
| Mar 2012 | - | $1.22 M(-42.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $2.13 M(+58.2%) | $2.13 M(+35.6%) |
| Sep 2011 | - | $1.57 M(-26.6%) |
| Jun 2011 | - | $2.14 M(-23.0%) |
| Mar 2011 | - | $2.77 M(+106.5%) |
| Dec 2010 | $1.34 M(-58.6%) | $1.34 M(-54.6%) |
| Sep 2010 | - | $2.96 M(+93.0%) |
| Jun 2010 | - | $1.53 M(-35.5%) |
| Mar 2010 | - | $2.38 M(-26.7%) |
| Dec 2009 | $3.25 M(-64.5%) | $3.25 M(-0.8%) |
| Sep 2009 | - | $3.27 M(+28.3%) |
| Jun 2009 | - | $2.55 M(-53.2%) |
| Mar 2009 | - | $5.46 M(-40.3%) |
| Dec 2008 | $9.13 M(-15.0%) | $9.13 M(-2.3%) |
| Sep 2008 | - | $9.34 M(+23.4%) |
| Jun 2008 | - | $7.57 M(+64.6%) |
| Mar 2008 | - | $4.60 M(-57.2%) |
| Dec 2007 | $10.74 M(+55.0%) | $10.74 M(+40.3%) |
| Sep 2007 | - | $7.66 M(-17.8%) |
| Jun 2007 | - | $9.32 M(+33.5%) |
| Mar 2007 | - | $6.98 M(+0.7%) |
| Dec 2006 | $6.93 M(-27.4%) | $6.93 M(-1.8%) |
| Sep 2006 | - | $7.06 M(+6.1%) |
| Jun 2006 | - | $6.65 M(-16.2%) |
| Mar 2006 | - | $7.93 M(-16.9%) |
| Dec 2005 | $9.55 M(+81.3%) | $9.55 M(+50.6%) |
| Sep 2005 | - | $6.34 M(+54.1%) |
| Jun 2005 | - | $4.12 M(+7.8%) |
| Mar 2005 | - | $3.82 M(-27.5%) |
| Dec 2004 | $5.27 M(-1.8%) | $5.27 M(+19.6%) |
| Sep 2004 | - | $4.40 M(+57.4%) |
| Jun 2004 | - | $2.80 M(-45.4%) |
| Mar 2004 | - | $5.13 M(-4.4%) |
| Dec 2003 | $5.36 M(+79.2%) | $5.36 M(+41.3%) |
| Sep 2003 | - | $3.79 M(+8.6%) |
| Jun 2003 | - | $3.49 M(+19.0%) |
| Mar 2003 | - | $2.94 M(-1.8%) |
| Dec 2002 | $2.99 M(+73.7%) | $2.99 M(+0.5%) |
| Sep 2002 | - | $2.98 M(-26.1%) |
| Jun 2002 | - | $4.03 M(+132.8%) |
| Mar 2002 | - | $1.73 M(-56.8%) |
| Dec 2001 | $1.72 M(+49.6%) | - |
| Aug 2001 | - | $4.01 M(+270.1%) |
| May 2001 | - | $1.08 M(+29.8%) |
| Feb 2001 | - | $834.30 K(-27.6%) |
| Nov 2000 | $1.15 M(+30.4%) | $1.15 M(+54.8%) |
| Aug 2000 | - | $744.10 K(-14.2%) |
| May 2000 | - | $867.60 K(+39.9%) |
| Feb 2000 | - | $620.20 K(-29.7%) |
| Nov 1999 | $882.80 K(-62.3%) | $882.80 K(+10.0%) |
| Aug 1999 | - | $802.90 K(-54.5%) |
| May 1999 | - | $1.76 M(+6.4%) |
| Feb 1999 | - | $1.66 M |
| Nov 1998 | $2.34 M | - |
FAQ
- What is Aurinia Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual current liabilities year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly current liabilities year-on-year change?
What is Aurinia Pharmaceuticals annual total current liabilities?
The current annual current liabilities of AUPH is $97.76 M
What is the all time high annual current liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total current liabilities is $97.76 M
What is Aurinia Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, AUPH annual total current liabilities has changed by +$20.57 M (+26.66%)
What is Aurinia Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of AUPH is $97.76 M
What is the all time high quarterly current liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total current liabilities is $97.76 M
What is Aurinia Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, AUPH quarterly total current liabilities has changed by +$20.86 M (+27.13%)